Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

Osmolex ER OK'd for Parkinson's Disease, Drug-Induced Extrapyramidal Reactions

By Feb 20, 2018

The approval of Osmolex ER was based on bioavailability studies comparing Osmolex ER to immediate-release amantadine.

Imfinzi Approved to Treat Stage III Non-Small Cell Lung Cancer

By Feb 20, 2018

The approval of Imfinzi is based on the positive PFS data from the Phase 3 PACIFIC trial.

CDC: Elevated Flu Activity Expected to Continue for Several More Weeks

By Feb 16, 2018

So far this season, influenza A(H3N2) viruses have predominated, but other influenza viruses are also circulating.

Availability of Decadron Tablets Announced

By Feb 16, 2018

Decadron is a first-generation adrenocortical steroid.

Sudden Cardiac Arrest, Ventricular Arrhythmia Risk Examined With Sulfonylureas

By Feb 16, 2018

Using U.S. Medicaid claims (1999-2010) from 5 states, the researchers sought to examine the association between individual sulfonylureas (glyburide, glimepiride, glipizide) and outpatient-originating SCA/VA; glipizide exposure was considered the reference exposure.

More Articles by Da Hee Han, PharmD